A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
Clinical trial NCT01198132 · COMPLETED
Trial details
- NCT number
- NCT01198132
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2015-03-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.